Cargando…
Structure, signaling and the drug discovery of the Ras oncogene protein
Mutations in Ras GTPase are among the most common genetic alterations in human cancers. Despite extensive research investigating Ras proteins, their functions still remain a challenge over a long period of time. The currently available data suggests that solving the outstanding issues regarding Ras...
Autores principales: | Han, Chang Woo, Jeong, Mi Suk, Jang, Se Bok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584742/ https://www.ncbi.nlm.nih.gov/pubmed/28571593 http://dx.doi.org/10.5483/BMBRep.2017.50.7.062 |
Ejemplares similares
-
Structural insights of homotypic interaction domains in the
ligand-receptor signal transduction of tumor necrosis factor
(TNF)
por: Park, Young-Hoon, et al.
Publicado: (2016) -
Structure and function of vascular endothelial growth factor and its receptor system
por: Park, Seong Ah, et al.
Publicado: (2018) -
Oncogenic KRAS: Signaling and Drug Resistance
por: Kim, Hyeon Jin, et al.
Publicado: (2021) -
A H-REV107 Peptide Inhibits Tumor Growth and Interacts Directly with Oncogenic KRAS Mutants
por: Han, Chang Woo, et al.
Publicado: (2020) -
Understand KRAS and the Quest for Anti-Cancer Drugs
por: Han, Chang Woo, et al.
Publicado: (2021)